Torsunate

Torsunate for Injection 30 mg, 60 mg, 120 mg & 180 mg

Dosage Form

Dry Powder Injection

Route of Administration

Intravenous (IV) / Intramuscular (IM)

Composition

Each vial contains:

Indications

Artesunate is indicated for the treatment of severe malaria caused by Plasmodium falciparum, Plasmodium malariae or Plasmodium ovale.

Storage

Store at a temperature not exceeding 30°C. Protect from light.

Precautions

Contraindicated in patients with hypersensitivity to artesunate or other artemisinins.
Artesunate should be used with caution in pregnancy, particularly during the first trimester.
Patients should be monitored for delayed haemolysis following treatment.
Local information regarding antimalarial resistance should be considered when selecting an appropriate combination antimalarial regimen.

Presentation

White to almost white crystalline powder filled in a clear glass vial, sealed with a grey butyl rubber stopper and 20 mm blue colour flip-off seal.

GLOBAL HORIZONS

Your Efforts Extended Through a Partnership That's Better Together